Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Question for Eoganacht

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon May 13, 2023 10:09am

168 Views

Post# 35446823

RE:RE:RE:RE:Question for Eoganacht

@DJDawg. The only way I see that 19 responders number is if we ignore the first 12 under treated patients. If that's what you meant, I get it. Maybe I missed it above. So TLT has more than the 25- patient data stipulated, even with the 12 removed. And the CR numbers at 450 days are better than the competition. Even if the 12 are added back into the count, we're still above 30% . Thanks for explaining.

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle